Adversomics: the emerging field of vaccine adverse event immunogenetics.

作者: Gregory A. Poland , Inna G. Ovsyannikova , Robert M. Jacobson

DOI: 10.1097/INF.0B013E3181A6A511

关键词:

摘要: Vaccines have enabled tremendous decreases in infectious diseases, eradication of smallpox, saved lives, and remain among the most effective cost-effective our public health initiatives.1 At same time, as an ever larger number vaccines are administered globally, increasing concerns about adverse events reactions been raised threaten successes attributable to vaccines. For example, controversy surrounding measles-mumps-rubella (MMR) vaccine thimerosal emblematic perceptions regarding safety (AEs). With current future technologic advances such high throughput whole-genome scanning, transcriptomics, epigenetics, proteomics, new biostatistical approaches understanding huge databases information, we can better understand associations mechanisms by which genetically-mediated individual variations response reactivity occur. Armed with knowledge, ability predict AEs, or design that minimize eliminate serious vaccine-related could be devised, consistent a more personalized approach practice called adversomics (the immunogenetics immunogenomics at population level, respectively).

参考文章(16)
V J Lund, D Goldblatt, J P Pandey, G K Scadding, A M Wade, M W Turner, ASSOCIATION OF GM ALLOTYPES WITH THE ANTIBODY-RESPONSE TO THE OUTER-MEMBRANE PROTEINS OF A COMMON UPPER RESPIRATORY-TRACT ORGANISM, MORAXELLA-CATARRHALIS Journal of Immunology. ,vol. 153, pp. 5316- 5320 ,(1994)
David N Juurlink, Therese A Stukel, Jeffrey Kwong, Alexander Kopp, Allison McGeer, Ross E Upshur, Douglas G Manuel, Rahim Moineddin, Kumanan Wilson, Guillain-Barré Syndrome After Influenza Vaccination in Adults: A Population-Based Study JAMA Internal Medicine. ,vol. 166, pp. 2217- 2221 ,(2006) , 10.1001/ARCHINTE.166.20.2217
E. K. France, J. Glanz, S. Xu, S. Hambidge, K. Yamasaki, S. B. Black, M. Marcy, J. P. Mullooly, L. A. Jackson, J. Nordin, E. A. Belongia, K. Hohman, R. T. Chen, R. Davis, , Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics. ,vol. 121, ,(2008) , 10.1542/PEDS.2007-1578
F. L. Black, W. Hierholzer, J. P. Woodall, F. Pinhiero, Intensified Reactions to Measles Vaccine in Unexposed Populations of American Indians The Journal of Infectious Diseases. ,vol. 124, pp. 306- 317 ,(1971) , 10.1093/INFDIS/124.3.306
DAVID BURGNER, MICHAEL LEVIN, Genetic susceptibility to infectious diseases. Pediatric Infectious Disease Journal. ,vol. 22, pp. 1- 6 ,(2003) , 10.1097/00006454-200301000-00002
David M. Reif, Brett A. McKinney, Alison A. Motsinger, Stephen J. Chanock, Kathryn M. Edwards, Michael T. Rock, Jason H. Moore, James E. Crowe, Jr., Genetic Basis for Adverse Events after Smallpox Vaccination The Journal of Infectious Diseases. ,vol. 198, pp. 16- 22 ,(2008) , 10.1086/588670
George R. Siber, Mathuram Santosham, G. Raymond Reid, Claudette Thompson, Janné Almeido-Hill, Andreas Morell, Gerda deLange, Jeffrey K. Ketcham, Elaine H. Callahan, Impaired Antibody Response toHaemophilus influenzaeType b Polysaccharide and Low IgG2 and IgG4 Concentrations in Apache Children New England Journal of Medicine. ,vol. 323, pp. 1387- 1392 ,(1990) , 10.1056/NEJM199011153232005
Gregory A. Poland, Inna G. Ovsyannikova, Robert M. Jacobson, Vaccine immunogenetics: bedside to bench to population. Vaccine. ,vol. 26, pp. 6183- 6188 ,(2008) , 10.1016/J.VACCINE.2008.06.057
G A Poland, I G Ovsyannikova, R M Jacobson, D I Smith, Heterogeneity in Vaccine Immune Response: The Role of Immunogenetics and the Emerging Field of Vaccinomics Clinical Pharmacology & Therapeutics. ,vol. 82, pp. 653- 664 ,(2007) , 10.1038/SJ.CLPT.6100415
Christopher B. Wilson, Edgar K. Marcuse, Vaccine safety–vaccine benefits:science and the public's perception Nature Reviews Immunology. ,vol. 1, pp. 160- 165 ,(2001) , 10.1038/35100585